← FDA DRUG APPROVALS

FDA NDA · NDA017256

XENON XE 133

Sponsor: GE HEALTHCARE

APPLICATION
NDA017256
TYPE
NDA
ORIGINAL APPROVAL
1976-11-09
LATEST ACTION
2001-09-17
ROUTE
INHALATION, INJECTION
DOSAGE FORM
GAS, INJECTABLE
MARKETING STATUS
Discontinued

Products

XENON XE 133Discontinued
XENON XE-133 1 CI/AMP · GAS · INHALATION
XENON XE 133Discontinued
XENON XE-133 1.3-1.7 CI/AMP · INJECTABLE · INJECTION

Approval history

2001-09-17Labeling · Supplement 13AP
2001-09-17Labeling · Supplement 12AP
1980-02-29Labeling · Supplement 7AP
1979-05-01Labeling · Supplement 6AP
1976-11-09Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →